Staff

TOP 5 publications:

1. Sartorius A, Demirakca T, Böhringer A, Clemm von Hohenberg C, Aksay SS, Bumb JM, Kranaster L, Nickl-Jockschat T, Grözinger M, Thomann PA, Wolf RC, Zwanzger P, Dannlowski U, Redlich R, Zavorotnyy M, Zöllner R, Methfessel I, Besse M, Zilles D, Ende G. Electroconvulsive therapy induced gray matter increase is not necessarily correlated with clinical data in depressed patients. Brain Stimul. 2019 12(2):335-343. Epub 2018 Dec 4.
2. Kranaster L, Hoyer C, Aksay SS, Bumb JM, Müller N, Zill P, Schwarz MJ, Sartorius A. Markers of the innate immune system in the cerebrospinal fluid in patients with severe depression. Acta Psychiatr Scand. 2017 136(1):140-141. Epub 2017 May 13.
3. Hoyer C, Sartorius A, Aksay SS, Bumb JM, Janke C, Thiel M, Haffner D, Leifheit-Nestler M, Kranaster L. Electroconvulsive therapy enhances the anti-ageing hormone Klotho in the cerebrospinal fluid of geriatric patients with major depression. Eur Neuropsychopharmacol. 2018 28(3):428-435. Epub 2017 Dec 20.
4. Kranaster L, Badstübner J, Aksay SS, Bumb JM, Suliman R, Neumaier M, Sartorius A. Evaluation of Myocardial Damage After Electroconvulsive Therapy: Analyses of High-Sensitive Cardiac Troponin I and N-Terminal pro-B-type Natriuretic Peptide. Pharmacopsychiatry. 2019 52(2):92-93. Epub 2018 Jul 2.
5. Kranaster L, Aksay SS, Bumb JM, Janke C, Alonso A, Hoyer C, Zerr I, Schmitz M, Hausner L, Frölich L, Sartorius A. Electroconvulsive therapy selectively enhances amyloid β 1-42 in the cerebrospinal fluid of patients with major depression: A prospective pilot study. Eur Neuropsychopharmacol. 2016 26(12):1877-1884. Epub 2016 Nov 18.